Zebra Analytix is thrilled to add William F McCoy, PhD, to its Board of Directors. The renowned innovator in chemistry, microbiology, and analytical diagnostics brings his extensive expertise to advance the company's mission of pioneering analytical technologies for enhanced safety and efficiency in various industries. https://hubs.ly/Q02lQlvk0 #medtech #diagnostics
Zebra Analytix’s Post
More Relevant Posts
-
Breaking News: Zebra Analytix Secures $1.8M NIH-NIEHS Grant for Cutting-Edge Toxic Gas Monitoring Technology! The Phase II grant milestone marks a leap forward in environmental health with innovative MEMS tech. https://lnkd.in/dHRpaxZM The National Institutes of Health National Institute of Environmental Health Sciences (NIEHS)
-
-
Come work for us!
We are #hiring! Know anyone who might be interested?
-
Explore the VIC Tech annual report featuring Zebra Analytix
Our Annual Report Executive Summary provides an overview of the significant progress made across the VIC ecosystem in 2023 and a preview of our plans for 2024. https://hubs.ly/Q02lQL4j0 #annualreport #lifescience #medtech
VIC 2023 Annual Report: Executive Summary
blog.victech.com
-
Introducing the MEMS Cluster-Column by Zebra Analytix We're excited to announce our latest breakthrough in miniaturized chromatography technology. The MEMS Cluster-Column revolutionizes the field, providing unique ability to generate full baseline separation of compounds which has not previously been achievable without the use of a mass spectrometer. https://hubs.ly/Q0286W_h0 #massspec #chromatography #massspectrometer
Zebra Analytix Launches an Advancement in Analytical Science with MEMS Cluster-Columns
blog.victech.com
-
Explore the VIC Tech mid-year report featuring Zebra Analytix
The VIC Tech Mid-Year Report is here! Despite the challenging fundraising landscape, VIC's portfolio companies have made remarkable progress in the first half of 2023. They have formed strategic partnerships, secured non-dilutive funding, and advanced product development with exceptional results in pre-clinical and clinical studies. https://hubs.ly/Q01ZDB0t0 #lifescience #medtech #healthcare #innovation
VIC 2023 Mid-Year Report
blog.victech.com
